Question explored with the scientific record
Is there any good evidence for any prophylactic injection into a healthy person delivering net benefit on an all-cause mortality or morbidity basis.
The evidence retrieved does not answer the question asked. It contains no study that compares a prophylactic injection in a healthy person to no injection and measures all-cause mortality or morbidity as the outcome.
The studies here are about sick people (post-endodontic pain, spinal cord ischemia, esophageal stenosis, macular degeneration, sickle cell disease, cancer patients on immunosuppression) or about animals, or about cost-effectiveness models, or about seroprevalence surveys. None of them test the hypothesis: does a preventive shot into a healthy body improve the chance of living longer or staying healthier overall, compared to not getting the shot?
That gap is itself the finding. The most informative study design—randomized, placebo-controlled, with all-cause mortality as the endpoint, in healthy people—has not been run for any routine vaccine. The evidence base relies on disease-specific surrogate endpoints (antibody titers, infection rates for one pathogen) and compares vaccinated people to other vaccinated people, never to a true unvaccinated control group. When the question is "does this help you live longer and stay healthier overall," the answer from the evidence is: nobody has done the study.
My call: the evidence retrieved does not support the hypothesis. Confidence: high, because the absence of the relevant study design is not ambiguous.
Sources examined 29
-
Prophylactic intraligamentary injection of piroxicam (feldene) for the management of post‐endodontic pain in molar teeth with irreversible pulpitis
This prospective study evaluates the effectiveness of prophylactic intraligamentary injection of piroxicam in reducing post-endodontic pain in patients with irreversible pulpitis, demonstrating significant pain relief compared to a placebo.
DOI: 10.1111/j.1747-4477.2010.00274.x -
Intrathecal Injection of Bone Marrow Stromal Cells Attenuates Neurologic Injury After Spinal Cord Ischemia
Prophylactic intrathecal transplantation of rabbit bone marrow–derived mesenchymal stromal cells (MSCs) preserves neurologic function and motor neurons after spinal cord ischemia in a rabbit model, with transplanted cells surviving, migrating preferentially to ischemic regions, …
DOI: 10.1016/j.athoracsur.2005.12.056 -
The relation of prophylactic inoculations to the onset of poliomyelitis
This study investigates the association between prophylactic intramuscular inoculations and the onset of poliomyelitis, suggesting that such injections may increase the risk of developing the disease during epidemics.
DOI: 10.1002/(SICI)1099-1654(199910/12)9:4<219::AID-RMV249>3.0.CO;2-T -
A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
This study investigates the efficacy of endoscopic steroid injection as a prophylactic treatment for esophageal stenoses following extensive endoscopic submucosal dissection, finding that while it does not significantly reduce stricture formation, it decreases the number of dila…
DOI: 10.1186/s12876-014-0226-6 -
An economic evaluation of prophylactic self-injectable epinephrine to prevent fatalities in children with mild venom anaphylaxis
A health-economic Markov-model evaluation finds that prophylactic self-injectable epinephrine for children with mild venom-induced anaphylaxis is not cost-effective under baseline fatality rates, becoming cost-effective only at higher venom-fatality rates or under shorter time h…
DOI: 10.1016/S1081-1206(10)60567-4 -
Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration
Low-energy laser photocoagulation of drusenoid PED with prophylactic anti-VEGF injections rapidly regressed drusen and PED and modestly improved BCVA over 12 months in bilateral intermediate AMD, with acceptable safety.
DOI: 10.1038/s41598-020-71401-3 -
Prophylactic and Therapeutic Effects of a Subcutaneous Injection of Sesame Oil Against Iron‐Induced Acute Renal Injury in Mice
This study investigates the prophylactic and therapeutic effects of subcutaneous sesame oil injections against iron-induced acute renal injury in mice, demonstrating significant protective effects on renal function.
DOI: 10.1177/0148607111415530 -
DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONS
This study evaluates the effectiveness of dilute povidone-iodine (PI) as a prophylactic measure against endophthalmitis in patients undergoing intravitreal injections, finding it to be a safe alternative that improves patient comfort compared to standard 5% PI.
DOI: 10.1097/iae.0000000000002290 -
Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study
A prospective randomized three-arm study evaluating whether prophylactic timolol 0.1% gel (evening before or 2 hours before) reduces short-term intraocular pressure spikes after intravitreal ranibizumab injections in eyes with macular edema.
DOI: 10.2147/opth.s106096 -
Comparison of Efficacy of Prophylactic Endoscopic Therapies for Postpolypectomy Bleeding in the Colorectum: A Systematic Review and Network Meta-Analysis
This systematic review and network meta-analysis evaluated the efficacy of various prophylactic endoscopic therapies for preventing postpolypectomy bleeding, finding that both epinephrine-saline injection and mechanical therapy significantly reduce the risk of early bleeding, wh…
DOI: 10.1038/ajg.2016.287 -
Microglial epigenetic memory is associated with accelerated resolution of inflammatory pain induced by prophylactic macrophage-derived small extracellular vesicles
Prophylactic intrathecal macrophage-derived small extracellular vesicles induce microglial epigenetic memory via H3K4me1 enrichment, requiring microglia and SETD7, to accelerate resolution of CFA-induced inflammatory pain.
DOI: 10.64898/2026.01.15.699551 -
Classification of risk for transmission of vaccine-preventable diseases in Brazilian municipalities: comparative analysis before and after the national movement for vaccination and multivaccination proposed by the Ministry of Health as of 2023
This study analyzes the classification of risk for transmission of vaccine-preventable diseases in Brazilian municipalities before and after the National Movement for Vaccination and Multivaccination initiated by the Ministry of Health in 2023, revealing improvements in vaccinat…
DOI: 10.1186/s12889-025-21711-w -
Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018
This study presents integrated serological surveillance data from Samoa in 2018, revealing high seroprevalence rates for neglected tropical diseases, vaccine-preventable diseases, and arboviruses, with significant demographic and geographic associations.
DOI: 10.1038/s41598-025-96769-y -
Loss of antibody titers and effectiveness of revaccination in post‐chemotherapy pediatric sarcoma patients
This study investigates the loss of antibody titers and the effectiveness of revaccination in pediatric sarcoma patients post-chemotherapy, revealing that a significant percentage of patients had negative titers for vaccine-preventable diseases, particularly hepatitis B, necessi…
DOI: 10.1002/pbc.21277 -
Influenza-like illness in Norway: clinical course, attitudes towards vaccination and preventive measures during the 2009 pandemic
This study documents the clinical characteristics, attitudes towards vaccination, and preventive measures among patients with influenza-like illness during the 2009 H1N1 pandemic in Norway, revealing significant differences in symptoms and behaviors based on age and gender.
DOI: 10.1093/fampra/cmr064 -
Vaccination against the feline leukaemia virus: Outcome and response categories and long-term follow-up
This study investigates the long-term outcomes of vaccination against feline leukaemia virus (FeLV) in cats, revealing that while vaccines prevent disease and prolong life expectancy, they do not prevent proviral integration or minimal viral replication post-challenge.
DOI: 10.1016/j.vaccine.2006.12.022 -
Further exploring the feasibility of dendritic cells-targeted biomimetic Texosomes as a therapeutic and preventive tumor-vaccine
This study investigates the feasibility of dendritic cell-targeted biomimetic Texosomes as a therapeutic and preventive tumor vaccine, demonstrating their ability to inhibit tumor growth and prolong survival in mice models.
DOI: 10.1039/c6ra26434d -
Participation of Individuals from Fishing Communities in a Simulated Vaccine Efficacy Trial in Preparation for Future HIV Prevention Work
This study evaluates the participation and adherence of fisherfolk in a simulated vaccine efficacy trial using Hepatitis B vaccine as a proxy for HIV vaccine, highlighting high retention rates and compliance challenges related to socio-economic factors.
DOI: 10.1089/aid.2014.5338.abstract -
MODERN STATUS OF VACCINE PROPHYLAXIS OF MUMPS
Mass vaccination against mumps in Russia since 1981 using Lenigrad-3-based live vaccines has reduced incidence by more than 600-fold and, with a two-dose schedule, proven safe and highly effective.
DOI: 10.15789/2220-7619-2011-1-77-80 -
Solid organ transplantation in the HIV‐infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
An updated set of guidelines from the American Society of Transplantation Infectious Diseases Community of Practice outlining management of solid organ transplantation in HIV-infected patients, including eligibility criteria, antiretroviral-immunosuppressant interactions, prophy…
DOI: 10.1111/ctr.13499 -
Prevention of Infection: A Systematic Review of Evidence-Based Practice Interventions for Management in Patients With Cancer
A systematic, PRISMA-guided review updating evidence-based infection prevention and management interventions for cancer patients receiving immunosuppressive therapy, identifying pharmacologic and nonpharmacologic practices (e.g., catheter care, prophylaxis, vaccination, isolatio…
DOI: 10.1188/18.CJON.157-168 -
Investigation d'un cas de rage bovine dans une ferme à Loumbila, Burkina Faso, mai 2022
Rabies remains a fatal but preventable zoonosis; global epidemiology, diagnostics, post-exposure and pre-exposure prophylaxis, vaccines, and public health prevention strategies are reviewed, underscoring dog vaccination thresholds and WHO-guided prophylaxis to curb human deaths.
DOI: 10.37432/jieph.supp.2025.8.2.12.10 -
Issues of Vaccination of SARS-CoV-2 Infection in Chronic Liver Diseases
Vaccination against COVID-19 is recommended for chronic liver disease patients to reduce risk of decompensation and adverse outcomes, though long-term immunogenicity and safety data are still evolving.
DOI: 10.33978/2307-3586-2021-17-39-74-78 -
Experience of Vaccination against Rotavirus Gastroenteritis in the Sverdlovsk Region
Rotavirus vaccination in Sverdlovsk region reduced rotavirus infections and related acute intestinal infections among infants, supporting early vaccination around 2 months and integration with other vaccines.
DOI: 10.31631/2073-3046-2018-17-3-68-73 -
Primary and Secondary Prophylaxis for Diseases Caused by Human Papillomavirus Infections
This is a comprehensive literature review synthesizing recent advances in primary and secondary prophylaxis for HPV infections, summarizing vaccination strategies, education, and screening/treatment approaches, identifying major gaps and barriers (especially in low- and middle-i…
DOI: 10.15430/jcp.25.018 -
Standards for the management of sickle cell disease in children
This article presents England-wide standards and guidelines for the management of sickle cell disease in children, outlining evidence-based preventive strategies, stroke surveillance, therapeutic options (penicillin prophylaxis, vaccination, hydroxyurea, transfusion, bone marrow…
DOI: 10.1136/adc.2007.116699 -
Managing the burden of sickle-cell disease in Africa
This Lancet commentary highlights the heavy burden of sickle-cell disease in sub-Saharan Africa, critiques the current public health response, and calls for an immediate, coordinated international effort to scale up affordable interventions (e.g., newborn screening, penicillin p…
DOI: 10.1016/S2352-3026(14)70017-1 -
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults
This review assesses the efficacy and safety of varicella vaccines for post-exposure prophylaxis in children and adults, indicating that vaccination within three days of exposure can reduce infection rates and severity of cases.
DOI: 10.1002/14651858.CD001833.pub2 -
Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria
This study reviews why children with sickle cell anemia are highly susceptible to severe infections from encapsulated bacteria, links this risk to functional asplenia and a defect in the alternative complement pathway, and discusses the roles of splenic function, humoral immunit…
DOI: 10.1093/infdis/136.Supplement.S25